FEBRUARY 20235TECH OUTLOOKCX O INSIGHTSNew Innovative Probiotics Reduces Risk of Aspirin-Induced UlcersAnders Damholt, PhD Biochemistry, Head of Clinical Development Human Health Innovation, and Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist, Human Health Innovation, Chr. Hansen16Challenges and Opportunities for AI in Drug DiscoveryRobert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.14The Rise in Outsourcing Clinical TrialsErika Vento-Gaudens, Director, Global Clinical Trial Operations, Guardant Health17Leveraging AI/ML to Transform Pharmaceutical IndustryAlexander Bernikov, Medical Director, Clinical Development (Uro)-Oncology, Jiangsu Hengrui Pharmaceuticals18The Challenging Aspects of Developing AI/ML-Based Diagnostic Pathology PlatformsDr. Kim M. Bonner, BSc (Hons) VMD PhD, Executive Director, Clinical Development, Syneos Health22Accelerating Early-Stage Drug DevelopmentSafwan Kezbor, M.D., Medical Director, Clinical Development, Shionogi Inc.20Challenges to Clinical System in ChinaCheryl Chen, Director of Clinical Operations, BeiGene23Impact of Real-World Evidence and Digital Innovation in HealthcareKelly H. Zou, Head, Global Medical Analytics and Real-World Evidence, Viatris26How to efficiently use Dose-Exposure-Response information and modern tools in DMPK and Safety sciences in drug discovery?Dr Riikka Oksala, Director, DMPK & Safety Sciences, R&D, Orion19Medical Affairs Takes Centre StageDr. Sarah Tregenza, PhD, BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre Group24C O NT E NT S
< Page 4 | Page 6 >